ID
43690
Description
Demography Ropinirole Case Report FormStudy ID: 100013 Clinical Study ID: RRL100013 A 12-Week, Double-Blind, Placebo-Controlled, Twice-Daily Dosing Study to Assess the Efficacy and Safety of Ropinirole in Patients Suffering from Restless Legs Syndrome (RLS) Requiring Extended Treatment Coverage
Keywords
Versions (2)
- 10/1/17 10/1/17 -
- 9/20/21 9/20/21 -
Copyright Holder
gsk
Uploaded on
September 20, 2021
DOI
To request one please log in.
License
Creative Commons BY-NC 3.0
Model comments :
You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.
Itemgroup comments for :
Item comments for :
In order to download data models you must be logged in. Please log in or register for free.
Screening demography Ropinirole Case Report Form GSK RRL100013
Screening demography Ropinirole Case Report Form GSK RRL100013
- StudyEvent: ODM
Description
DEMOGRAPHY
Alias
- UMLS CUI-1
- C0011298
Description
date of birth
Data type
date
Alias
- UMLS CUI [1]
- C0421451
Description
sex
Data type
text
Alias
- UMLS CUI [1]
- C0079399
Description
Race
Data type
text
Alias
- UMLS CUI [1]
- C0034510
Similar models
Screening demography Ropinirole Case Report Form GSK RRL100013
- StudyEvent: ODM
(Comment:en)
(Comment:en)
(Comment:en)
(Comment:en)
(Comment:en)
(Comment:en)
(Comment:en)
(Comment:en)
(Comment:en)
No comments